Skip to main content
logo
Abera Bioscience AB (NGM:ABERA)
Sweden flag Sweden · Delayed Price · Currency is SEK
8.86
+0.04 (0.45%)
At close: Jul 24, 2026

Abera Bioscience AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
11.8311.8514.632.521.791.18
Revenue Growth
-25.75%-18.99%479.60%41.18%51.78%55.92%
Gross Profit
11.8311.8514.632.521.791.18
Operating Income
-16.45-10.61-1.34-16.92-19.45-9.18
Net Income
-16.26-10.45-1.1-16.72-19.38-9.17
Earnings Per Share
-0.79-0.63-0.07-1.26-1.66-0.90
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
26.0423.496.093.3215.4311.95
Net Cash Growth
373.39%285.70%83.49%-78.50%29.13%1224.40%
Net Cash Per Share
1.271.420.390.251.321.17
Cash & Investments
26.0423.496.093.3215.4311.95

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.11-3.26-0.2-17.71-19.69-9.68
Capital Expenditures
-0.43-0.43-1.13---
Free Cash Flow
-10.54-3.68-1.33-17.71-19.69-9.68
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-139.03%-89.56%-9.15%-670.48%-1088.19%-779.01%
Pretax Margin
-137.46%-88.20%-7.52%-662.44%-1084.01%-778.09%
Profit Margin
-137.46%-88.20%-7.52%-662.44%-1084.01%-778.09%
FCF Margin
-89.08%-31.09%-9.09%-701.70%-1101.46%-821.76%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
15.3510.594.7329.5734.66146.97